| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Banyu Tsukuba Research Institute (Merck), Tsukuba 300-2611 [N. H., H. M., H. O., N. M., M. O., Y. T.]; Laboratory of Biomedical Genetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033 [M. M. T.]; and Department of Pharmacology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501 [H. O., M. O., M. M. T.], Japan
Mutations in the glycogen synthase kinase 3ß (GSK3ß) phosphorylation sites of the ß-catenin gene exon 3 are found in 2030% of human primary hepatocellular carcinoma (HCC), whereas mutations in the APC or AXIN genes are found in other HCC populations. These data strongly suggest that the Wnt signaling pathway is involved in hepatocarcinogenesis. To determine the role of ß-catenin in intestinal tumorigenesis, we earlier constructed a mutant mouse strain Catnblox(ex3), in which exon 3 of the ß-catenin gene was sandwiched by loxP sequences. By genetic crosses of these mice with the Fabpl-cre transgenic mice that express the cre gene controlled by the fatty acid binding protein gene promoter, we introduced the ß-catenin stabilizing mutation into the small intestine and liver. Although numerous polyps were formed in the small intestine, we did not find any neoplastic (i.e., dysplastic) foci in the liver, and the mice died in 5 weeks after birth because of acute liver damage accompanying mitochondrial swelling. When a recombinant adenovirus that expresses the cre gene from a human cytomegalovirus early gene promoter was constructed and inoculated at a high multiplicity (109 plaque-forming units/mouse), the Catnblox(ex3) mice showed marked hepatomegaly, with similar mitochondrial swelling in the hepatocytes, and died within 3 weeks after infection. On the other hand, when inoculated at lower multiplicities of infection (107 and 108 plaque-forming units/mouse, respectively), the Catnblox(ex3) mice survived >6 months without any neoplastic foci in the liver, although the nuclear localization of ß-catenin was found in some hepatocytes even after 6 months. These results suggest that, in contrast to intestinal polyposis, the Wnt pathway activation by stabilized ß-catenin is not sufficient for hepatocarcinogenesis, but additional mutations or epigenetic changes may be required.
This article has been cited by other articles:
![]() |
S. Zuklys, J. Gill, M. P. Keller, M. Hauri-Hohl, S. Zhanybekova, G. Balciunaite, K.-J. Na, L. T. Jeker, K. Hafen, N. Tsukamoto, et al. Stabilized {beta}-Catenin in Thymic Epithelial Cells Blocks Thymus Development and Function J. Immunol., March 1, 2009; 182(5): 2997 - 3007. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Reed, D. Athineos, V. S. Meniel, J. A. Wilkins, R. A. Ridgway, Z. D. Burke, V. Muncan, A. R. Clarke, and O. J. Sansom B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver PNAS, December 2, 2008; 105(48): 18919 - 18923. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Grigoryan, P. Wend, A. Klaus, and W. Birchmeier Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of {beta}-catenin in mice Genes & Dev., September 1, 2008; 22(17): 2308 - 2341. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Schmidt, C. S. Chiariello, E. Capilla, F. Miller, and W. F. Bahou Development of Hepatocellular Carcinoma in Iqgap2-Deficient Mice Is IQGAP1 Dependent Mol. Cell. Biol., March 1, 2008; 28(5): 1489 - 1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamamoto, T. Ozaki, M. Nakanishi, H. Kikuchi, K. Yoshida, H. Horie, H. Kuwano, and A. Nakagawara Oxidative stress induces p53-dependent apoptosis in hepatoblastoma cell through its nuclear translocation Genes Cells, April 1, 2007; 12(4): 461 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Cheon, Q. Wei, A. Gurung, A. Youn, T. Bright, R. Poon, H. Whetstone, A. Guha, and B. A. Alman Beta-catenin regulates wound size and mediates the effect of TGF-beta in cutaneous healing FASEB J, April 1, 2006; 20(6): 692 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Mucenski, J. M. Nation, A. R. Thitoff, V. Besnard, Y. Xu, S. E. Wert, N. Harada, M. M. Taketo, M. T. Stahlman, and J. A. Whitsett {beta}-Catenin regulates differentiation of respiratory epithelial cells in vivo Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L971 - L979. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Boerboom, M. Paquet, M. Hsieh, J. Liu, S. P. Jamin, R. R. Behringer, J. Sirois, M. M. Taketo, and J. S. Richards Misregulated Wnt/{beta}-Catenin Signaling Leads to Ovarian Granulosa Cell Tumor Development Cancer Res., October 15, 2005; 65(20): 9206 - 9215. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Colnot, T. Decaens, M. Niwa-Kawakita, C. Godard, G. Hamard, A. Kahn, M. Giovannini, and C. Perret Liver-targeted disruption of Apc in mice activates {beta}-catenin signaling and leads to hepatocellular carcinomas PNAS, December 7, 2004; 101(49): 17216 - 17221. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sharma, A. Pradeep, L. Wong, A. Rana, and B. Rana Peroxisome Proliferator-activated Receptor {gamma} Activation Can Regulate {beta}-Catenin Levels via a Proteasome-mediated and Adenomatous Polyposis Coli-independent Pathway J. Biol. Chem., August 20, 2004; 279(34): 35583 - 35594. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. J. Sansom, K. R. Reed, A. J. Hayes, H. Ireland, H. Brinkmann, I. P. Newton, E. Batlle, P. Simon-Assmann, H. Clevers, I. S. Nathke, et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration Genes & Dev., June 15, 2004; 18(12): 1385 - 1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Harada, H. Oshima, M. Katoh, Y. Tamai, M. Oshima, and M. M. Taketo Hepatocarcinogenesis in Mice with {beta}-Catenin and Ha-Ras Gene Mutations Cancer Res., January 1, 2004; 64(1): 48 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Levy, C. Neuveut, C.-A. Renard, P. Charneau, S. Branchereau, F. Gauthier, J. T. Van Nhieu, D. Cherqui, A.-F. Petit-Bertron, D. Mathieu, et al. Transcriptional Activation of Interleukin-8 by beta -Catenin-Tcf4 J. Biol. Chem., October 25, 2002; 277(44): 42386 - 42393. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |